International: +1-347-960-6455

Research Reports

Filter By Therapeutic Area

Filtered by Report Category (Marketed Drug Insights and Forecast Reports)

Therapy Area
Tosymra - Drug Insight and Forecast, 2018
Therapeutic Area(s) Neurology

Tosymra, previously known as DFN-02, an intranasal spray containing sumatriptan (10 mg) and a 5-HT1B/1D receptor agonist developed by Dr. Reddy’s Laboratories Limited and its subsidiary Promius Pharma, LLC, is approved by the USFDA in January, 2019 for the acute migraine.

Therapy Area
Osphena - Drug Insight and Forecast, 2018
Therapeutic Area(s) Others

Osphena (Ospemifene), an estrogen receptor agonist with tissue selective effects. It is prescribed for painful intercourse (dyspareunia), which is a major symptom of vulvular and vagina muscular wasting (vaginal atrophy), due to menopause.

Therapy Area
Dasatinib - Drug Insight and Forecast, 2018
Therapeutic Area(s) OncologyOthers

Dasatinib (Sprycel) medicines are generally used to treat people with chronic myeloid leukemia and people with acute lymphoblastic leukemia who have been tested positive for the Philadelphia chromosome (Ph+).